-
at Houston, Rice University, Baylor College of Medicine, University of Texas MD Anderson Cancer Center, and Methodist Research Institute. What we want The Institute of Biosciences and Technology (IBT) of Texas
-
therapeutic response and resistance to RAS inhibition in non-small cell lung cancer (NSCLC) in the laboratory of Ferdinandos Skoulidis, MD, PhD at the University of Texas MD Anderson Cancer Center in Houston
-
Evolution Laboratory of Peter Van Loo at the University of Texas MD Anderson Cancer Center. The post holders will spearhead projects in large-scale cancer genomics and evolution. The Cancer Genomics and
Searches related to phd
Enter an email to receive alerts for phd "University of Texas MD Anderson Cancer Center" positions